Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Amal M. Johnson Sells 4,635 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Intuitive Surgical Trading Up 0.1 %

Intuitive Surgical stock traded up $0.66 on Tuesday, hitting $574.14. 2,331,432 shares of the stock traded hands, compared to its average volume of 2,043,553. The firm has a market cap of $204.50 billion, a P/E ratio of 92.31, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The business’s fifty day simple moving average is $548.00 and its 200 day simple moving average is $506.12. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently bought and sold shares of the business. AQR Capital Management LLC lifted its position in shares of Intuitive Surgical by 12.6% during the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock valued at $18,958,000 after buying an additional 4,775 shares in the last quarter. Creative Planning lifted its holdings in Intuitive Surgical by 9.8% in the 2nd quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock worth $28,043,000 after purchasing an additional 5,629 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in Intuitive Surgical by 8.2% in the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock worth $6,150,000 after purchasing an additional 1,044 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in Intuitive Surgical by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock worth $9,100,000 after purchasing an additional 411 shares in the last quarter. Finally, Wellington Wealth Strategies LLC. purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $241,000. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several analyst reports. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday. They set a “neutral” rating and a $550.00 price objective for the company. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.